Navigation Links
NPS Pharmaceuticals to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
Date:2/29/2008

BEDMINSTER, N.J., Feb. 29 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that Francois Nader, M.D., executive vice president, chief operating officer, and chief executive officer-elect is scheduled to present at the Lehman Brothers Eleventh Annual Global Healthcare Conference in Miami on Wednesday, March 19, 2008 at 3:15 p.m. ET. The presentation will be available as a live webcast with a replay available approximately 24 hours after the presentation has concluded. Interested parties may access the webcast from the NPS website, http://www.npsp.com.

About NPS Pharmaceuticals

NPS Pharmaceuticals is developing high value specialty therapeutics for gastrointestinal and endocrine disorders. The company is currently advancing two late-stage programs: GATTEX(TM) (teduglutide) is in Phase 3 clinical development for intestinal failure associated with short bowel syndrome and parathyroid hormone 1-84 [rDNA origin] injection is in Phase 2 clinical development as a hormone therapy for hypoparathyroidism. NPS has also completed a Phase 3 osteoporosis study for PREOS(R) (parathyroid hormone 1-84 [rDNA origin] injection). NPS complements its internal programs with strategic partnerships, which include Amgen, GlaxoSmithKline, Kirin, and Nycomed. Additional information is available at http://www.npsp.com.


'/>"/>
SOURCE NPS Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel
2. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
3. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
4. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
5. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
6. Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Results on Thursday, March 6, 2008
7. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
8. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
9. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
10. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
11. JSJ Pharmaceuticals Announces Launch of Aesthetic Division - Vitivia(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ... voluntary recall of five lots and voluntary market withdrawal ... Daytrana ® . Shire is taking this action because ... future may not meet their release liner removal specification, ...
(Date:12/3/2009)... -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer ... ), spoke at a conference on High-Risk Diabetic,Foot ... Beike is China,s leading,stem cell research and regenerative ... conference, organized by the Indian Podiatry Association (IPA), ...
(Date:12/2/2009)... announces that a new market research report ... Carbondioxide Incubators - A Global Market Perspective ... Incubators are the most critical equipment used ... applications for providing a controlled environment to ...
(Date:12/2/2009)... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion ... trial of Cotara® in patients with relapsed glioblastoma multiforme ... is a targeted monoclonal antibody linked to a radioisotope ... Cotara specifically targets cells at the center of ...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
... 4 The Cytokine Institute (TCI), a Los,Angeles-based ... the opening of a new office in the ... measures and analyzes the effects of,chemical and toxic ... Boston-based consulting arm, Green Reach Consulting, TCI now ...
... 4 Telik, Inc.,(Nasdaq: TELK ) announced that ... Annual Bear Stearns Healthcare Conference in New York,City on ... (8:30 a.m.,Pacific time). Telik,s presentation will be webcast live ... http://www.telik.com, ,through September 18, 2007. Telik, Inc. ...
... 4 Catalyzing an entire,new industry for North ... Biofuels Center of North Carolina, which moved to ... Funded with a $5 million initial appropriation ... in coming years implement North,Carolina,s Strategic Plan for ...
Other Biology Technology:Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases 2N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation 2N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation 3
(Date:12/4/2009)... constantly compete with one another for space and dominance. Though ... well known to be the survival of the fittest, how ... not as clear. A study on fruit flies published in ... Hopkins researchers describes how stem cells win this battle by ...
(Date:12/4/2009)... activity in organs relevant for coronary artery disease (CAD), ... identified a module of genes that is important for ... plaque. The findings, which are to be published in ... targeting the migration of white blood cells in the ...
(Date:12/4/2009)... , A new study of the Max Planck ... positive effect of dietary restriction on healthy ageing. Previous evidence ... dietary restriction increases longevity, but with a potential negative side ... less frequently with a reduced litter size on a low ...
Breaking Biology News(10 mins):Stem cells battle for space 2Scientists discover gene module underlying atherosclerosis development 2How nutrition affects healthy aging 2Frost 26amp 3B Sullivan to Discuss Investment Patterns in the Healthcare Industry in Free Webinar 59240 1Frost 26amp 3B Sullivan to Discuss Investment Patterns in the Healthcare Industry in Free Webinar 59240 2Torrids Model Search Winners Celebrities Celebrate Fashion and Help Support the National Breast Cancer Foundation at the House of Dreams Event 59235 1Torrids Model Search Winners Celebrities Celebrate Fashion and Help Support the National Breast Cancer Foundation at the House of Dreams Event 59235 2Body Clock Blood Sugar Control Seem Linked 59234 1Body Clock Blood Sugar Control Seem Linked 59234 2
... are arriving earlier each spring as temperatures warm along ... farther those birds journey, the less likely they are ... Scientists at Boston University and the Manomet Center for ... migrations of 32 species of birds along the coast ...
... in neural tissue engineering, has been awarded a prestigious ... Foundation (NSF). Pfister, who is an assistant ... Engineering, received the award to support and expand his ... regenerating damaged or diseased nerve cells. , In collaboration ...
... people don,t think twice as they pass spring apples from ... are participating in a cheap food revolution that has swept ... supermarket is the last step in a complicated global process ... consume food. In theory, the arrival of supermarkets in a ...
Other Biology News:Birds migrate earlier, but some may be left behind as the climate warms rapidly 2NJIT biomedical engineer receives NSF Career Development Award 2Lost in the supermarket? 2
Sf21 cells derived from Spodoptera frugiperda ovarian cells are recommended for high-level production of recombinant proteins. Higher expression levels of some proteins are seen due to the larger ce...
... This kit consists of universal lysis ... control primers for 100 25 l volume ... types of Gram negative or positive rod ... Klebsiella Pneumoniae, Bacillus Cereus, Staphylococcus Aureus, Streptococcus ...
...
TNM-FH Insect Medium 1 liter...
Biology Products: